Acute respiratory distress syndrome: Difference between revisions

From IDWiki
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations")
No edit summary
Line 1: Line 1:
== Summary ==
== Background ==


* Lung damage that occurs within one week of an insult, with bilateral CXR opacities, not explain by other causes
* Lung damage that occurs within one week of an insult, with bilateral CXR opacities, not explain by other causes
Line 6: Line 6:
** V<s>T</s> 6mL/kg predicted body weight, plateau pressure ≤30 cmH<s>2</s>O, SpO2 88-95%, and pH 7.3-7.45
** V<s>T</s> 6mL/kg predicted body weight, plateau pressure ≤30 cmH<s>2</s>O, SpO2 88-95%, and pH 7.3-7.45


== Definition ==
=== Definition ===


* Syndrome of diffuse alveolar and interstitial edema
* Syndrome of diffuse alveolar and interstitial edema
* &quot;[https://doi.org/10.1007/s00134-005-2627-z Baby lung]&quot;: small effective lung volume, because the dependent portions are filled with fluid
* &quot;[https://doi.org/10.1007/s00134-005-2627-z Baby lung]&quot;: small effective lung volume, because the dependent portions are filled with fluid


== [https://doi.org/10.1001/jama.2012.5669 Berlin Definition (2012)] ==
===[https://doi.org/10.1001/jama.2012.5669 Berlin Definition (2012)]===


* Syndrome, not disease, per European task force in 2012
* Syndrome, not disease, per European task force in 2012
Line 18: Line 18:
* Chest imaging bilateral opacities not otherwise explained
* Chest imaging bilateral opacities not otherwise explained
* Severity based on oxygenation
* Severity based on oxygenation
** Mild: ratio of PaO<s>2</s>/FiO<s>2</s> between 200-300 with PEEP over 5 cmH<s>2</s>O (27% mortality)
** Mild: ratio of PaO<sub>2</sub>/FiO<sub>2</sub> between 200-300 with PEEP over 5 cmH<sub>2</sub>O (27% mortality)
** Moderate: ratio between 100 and 200 with PEEP over 5 cmH<s>2</s>O (32% mortality)
** Moderate: ratio between 100 and 200 with PEEP over 5 cmH<sub>2</sub>O (32% mortality)
** Severe: ratio below 100 with PEEP over 5 cmH<s>2</s>O (45% mortality)
** Severe: ratio below 100 with PEEP over 5 cmH<sub>2</sub>O (45% mortality)


== Causes ==
=== Etiologies ===


* Direct
* Direct
Line 39: Line 39:
** Amniotic fluid embolism
** Amniotic fluid embolism


== Pathophysiology ==
=== Pathophysiology ===


* Acute edema from neutrophil activation, with formation of hyaline membranes, and eventual fibrosis
* Acute edema from neutrophil activation, with formation of hyaline membranes, and eventual fibrosis
* Type I pneumocytes replaced with type II
* Type I pneumocytes replaced with type II
* Increased alveolar permeability leading to non-hydrostatic pulmonary edema
* Lungs become less compliant, due to a decrease in the available lung volume
* Lungs become less compliant, due to a decrease in the available lung volume

== Clinical Manifestations ==

* Dyspnea and escalating ventilatory requirements following a known cause of ARDS


== Differential Diagnosis ==
== Differential Diagnosis ==


* ARDS (50%)
* ARDS (50%)
* Pneumonia (25%)
* [[Pneumonia]] (25%)
* Pulmonary edema (11%)
* [[Pulmonary edema]] (11%)
* Invasive aspergillosis (6%)
* [[Invasive aspergillosis]] (6%)
* Pulmonary embolism (3%)
* [[Pulmonary embolism]] (3%)
* Other (5%)
* Other (5%)

== Clinical Manifestations ==

* Dyspnea and escalating ventilatory requirements following a known cause of ARDS


== Investigations ==
== Investigations ==
Line 67: Line 68:
== Management ==
== Management ==


=== All Patients ===
* Lung-protective ventilation (see [[ARDS ventilation protocol]])
* Lung-protective ventilation (see [[ARDS ventilation protocol]])
** Targets tidal volume of 6mL/kg predicted body weight, plateau pressure ≤30 cmH2O, SpO2 88-95%, and pH 7.3-7.45
** Targets tidal volume of 6mL/kg predicted body weight, plateau pressure ≤30 cmH2O, SpO2 88-95%, and pH 7.3-7.45
** Decrease tidal volume from 8mL/kg to 6mL/kg predicted body weight over 4 hours, then continue to decrease in 1mL/kg increments until plateau pressures &lt;30 or tidal volume 4mL/kg
** Decrease tidal volume from 8mL/kg to 6mL/kg predicted body weight over 4 hours, then continue to decrease in 1 mL/kg increments until plateau pressures &lt;30 or tidal volume 4mL/kg
** PEEP over 15 cmH<s>2</s>O [https://doi.org/10.1001/jama.2010.218 may be protective in severe ARDS]
** PEEP over 15 cmH<sub><s>2</s></sub>O [https://doi.org/10.1001/jama.2010.218 may be protective in severe ARDS]
** Permissive hypercapnia to CO2 60-70 and pH 7.2-7.25, if needed
** Permissive hypercapnia to CO<sub>2</sub> 60-70 and pH 7.2-7.25, if needed
* Prone positioning
* Maintain euvolemia
* Maintain euvolemia

=== Severe ARDS ===

* Prone positioning
* vv-[[ECMO]]


[[Category:Critical care]]
[[Category:Critical care]]

Revision as of 02:28, 29 August 2021

Background

  • Lung damage that occurs within one week of an insult, with bilateral CXR opacities, not explain by other causes
  • Severity based on P:F ratio: severe <100, moderate 100-200, and mild 200-300
  • Lung protective ventilation reduces mortality
    • VT 6mL/kg predicted body weight, plateau pressure ≤30 cmH2O, SpO2 88-95%, and pH 7.3-7.45

Definition

  • Syndrome of diffuse alveolar and interstitial edema
  • "Baby lung": small effective lung volume, because the dependent portions are filled with fluid

Berlin Definition (2012)

  • Syndrome, not disease, per European task force in 2012
  • Timing: within 1 week of a known insult
  • Origin of edema: not cardiac or hydrostatic edema
  • Chest imaging bilateral opacities not otherwise explained
  • Severity based on oxygenation
    • Mild: ratio of PaO2/FiO2 between 200-300 with PEEP over 5 cmH2O (27% mortality)
    • Moderate: ratio between 100 and 200 with PEEP over 5 cmH2O (32% mortality)
    • Severe: ratio below 100 with PEEP over 5 cmH2O (45% mortality)

Etiologies

  • Direct
    • Pneumonia
    • Aspiration
    • Inhalational injury
    • Pulmonary contusion
    • Near-drowning
  • Indirection
    • Sepsis
    • Major trauma
    • Multiple blood product transfusions
    • Pancreatitis
    • Shock
    • Drug overdose
    • Amniotic fluid embolism

Pathophysiology

  • Acute edema from neutrophil activation, with formation of hyaline membranes, and eventual fibrosis
  • Type I pneumocytes replaced with type II
  • Increased alveolar permeability leading to non-hydrostatic pulmonary edema
  • Lungs become less compliant, due to a decrease in the available lung volume

Clinical Manifestations

  • Dyspnea and escalating ventilatory requirements following a known cause of ARDS

Differential Diagnosis

Investigations

  • Chest x-ray showing bilateral infiltrates
  • Bronchoalveolar lavage (BAL)
    • Excludes the diagnosis if less than 5% neutrophils (can be over 80% in ARDS)
    • Suggestive if lavage to plasma protein ratio > 0.7 (less than 0.5 in hydrostatic edema)

Management

All Patients

  • Lung-protective ventilation (see ARDS ventilation protocol)
    • Targets tidal volume of 6mL/kg predicted body weight, plateau pressure ≤30 cmH2O, SpO2 88-95%, and pH 7.3-7.45
    • Decrease tidal volume from 8mL/kg to 6mL/kg predicted body weight over 4 hours, then continue to decrease in 1 mL/kg increments until plateau pressures <30 or tidal volume 4mL/kg
    • PEEP over 15 cmH2O may be protective in severe ARDS
    • Permissive hypercapnia to CO2 60-70 and pH 7.2-7.25, if needed
  • Maintain euvolemia

Severe ARDS

  • Prone positioning
  • vv-ECMO